These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6673031)

  • 81. Peculiarities in dermatology. A case of the Thiebierge-Weissen-bach type of systemic scleroderma associated with circumscribed calcinosis and Raynaud's disease.
    Kingsley HJ
    Cent Afr J Med; 1968 Mar; 14(3):59-60. PubMed ID: 5649072
    [No Abstract]   [Full Text] [Related]  

  • 82. Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon.
    Biondi ML; Marasini B; Bianchi E; Agostoni A
    Int J Cardiol; 1988 Jun; 19(3):335-9. PubMed ID: 3397197
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Changes in the blood surface-active properties during the correction of hemorheological disorders in patients with occlusive lesions of the abdominal aorta and arteries of the extremities].
    Kovalenko VI; Biul' EV; Serebrovskaia IA; Baturin LI
    Kardiologiia; 1985 Feb; 25(2):43-6. PubMed ID: 3990078
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
    Clements PJ
    Curr Opin Rheumatol; 1993 Nov; 5(6):749-52. PubMed ID: 8117537
    [No Abstract]   [Full Text] [Related]  

  • 85. Local increase of blood viscosity during cold-induced Raynaud's phenomenon.
    Forconi S; Guerrini M; Rossi C; Pecchi S
    Vasa; 1979; 8(2):116-20. PubMed ID: 463282
    [No Abstract]   [Full Text] [Related]  

  • 86. Raynaud's disease and oral contraceptives.
    Jarrett PE
    Br Med J; 1976 Sep; 2(6037):699. PubMed ID: 974553
    [No Abstract]   [Full Text] [Related]  

  • 87. Proceedings: Changes in blood viscosity and plasma proteins with Raynaud's phenomenon.
    Tietjen GW; Chien S; LeRoy EC; Gavras I; Gump FE
    J Cardiovasc Surg (Torino); 1976; 17(1):86. PubMed ID: 1245517
    [No Abstract]   [Full Text] [Related]  

  • 88. Increased plasma endothelin levels in patients with Raynaud's phenomenon.
    Biondi ML; Marasini B; Bassani C; Agastoni A
    N Engl J Med; 1991 Apr; 324(16):1139-40. PubMed ID: 2008192
    [No Abstract]   [Full Text] [Related]  

  • 89. [Acrocyanosis, Raynaud's phenomenon and digital gangrene in a case of systemic lupus erythematosus].
    Montuori R; Riccardi C
    Minerva Med; 1968 Feb; 59(10):515-21. PubMed ID: 5642234
    [No Abstract]   [Full Text] [Related]  

  • 90. [Erythrocyte filtration, platelet aggregation and hemocoagulative parameters in patients with Raynaud's disease].
    Macchione C; Molaschi M; Garrone MT; Neirotti M; Pesavento M; Longo F
    Minerva Cardioangiol; 1983 Sep; 31(9):461-3. PubMed ID: 6669261
    [No Abstract]   [Full Text] [Related]  

  • 91. [The influence of hemorrheology on the practice of clinical medicine].
    Dormandy JA
    Ric Clin Lab; 1983; 13 Suppl 3():7-27. PubMed ID: 6369497
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Statistical study on the effect of erythrocyte aggregation on blood filterability].
    Sergio G; Artale F; Espureo M; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():323-6. PubMed ID: 6673007
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis.
    Dowd PM; Kovacs IB; Bland CJ; Kirby JD
    Br Med J (Clin Res Ed); 1981 Aug; 283(6287):350. PubMed ID: 6788326
    [No Abstract]   [Full Text] [Related]  

  • 94. Generalized scleroderma with Raynaud's phenomena. Report of a case.
    Elmostehy MR; Bissada NF
    Egypt Dent J; 1970 Jan; 16(1):83-8. PubMed ID: 5268450
    [No Abstract]   [Full Text] [Related]  

  • 95. Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome.
    Belch JJ; McLaren M; Anderson J; Lowe GD; Sturrock RD; Capell HA; Forbes CD; Mikhailidis DP; Jeremy JY; Dandona P
    Prostaglandins Leukot Med; 1985 Jun; 18(3):401-2. PubMed ID: 3895252
    [No Abstract]   [Full Text] [Related]  

  • 96. [Preliminary study on erythrocyte filterability and other hemorrheological parameters in arteriosclerotic vascular disease].
    Pernigotti L; Neirotti M
    Ric Clin Lab; 1983; 13 Suppl 3():423-6. PubMed ID: 6673024
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Raynaud's phenomenon and blood viscosity.
    Ernst E
    Br J Surg; 1981 Jul; 68(7):520. PubMed ID: 7248730
    [No Abstract]   [Full Text] [Related]  

  • 98. [Platelet aggregation and Raynaud's phenomenon].
    Soro P; Farris A; Serra G; Denti S; Moretti P; Maoddi P; Bresadola F
    Angiologia; 1985; 37(1):13-7. PubMed ID: 3985417
    [No Abstract]   [Full Text] [Related]  

  • 99. Letter: Abnormal blood viscosity in Raynaud's phenomenon.
    Forconi S; Guerrini M; Agnusdei D; Pasini FL; di Perri T
    Lancet; 1976 Sep; 2(7985):586. PubMed ID: 60674
    [No Abstract]   [Full Text] [Related]  

  • 100. Haemorrheological response to plasma exchange in Raynaud's syndrome.
    Dodds AJ; O'Reilly MJ; Yates CJ; Cotton LT; Flute PT; Dormandy JA
    Br Med J; 1979 Nov; 2(6199):1186-87. PubMed ID: 519354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.